Business Context and Reporting Period
Company: The Gorman-Rupp Company
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2004
Business Overview: The Company manufactures and sells pumps and related equipment. The reporting period includes the effects of a 5-for-4 stock split effective September 10, 2004.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Sep 30, 2004 | 9 Months Ended Sep 30, 2004 |
|---|---|---|
| Net Sales | $52,392 | $152,627 |
| Gross Profit | $10,860 | $31,776 |
| Operating Income | $3,273 | $10,223 |
| Net Income | $2,056 | $6,712 |
| Diluted EPS | $0.19 | $0.63 |
| Cash from Operations (9mo) | $13,676 | |
| Cash & Equivalents (Sep 30, 2004) | $20,170 | |
| Current Ratio | 4.2 to 1 |
Material Changes vs. Prior Period
Third Quarter 2004 vs. Third Quarter 2003
- Net Sales: Decreased 2.1% to $52.4 million, primarily due to municipalities postponing capital spending projects.
- Net Income: Decreased 19.5% to $2.1 million. This decline was driven by lower sales volume and higher material costs, partially offset by a $1.25 million reduction in pension settlement losses compared to the prior year.
- Expenses: Selling, General, and Administrative (SG&A) expenses increased 2.8% due to higher professional fees for Sarbanes-Oxley compliance ($270,000) and marketing costs ($260,000).
Nine Months 2004 vs. Nine Months 2003
- Net Sales: Increased 4.1% to $152.6 million, reflecting a general economic recovery.
- Net Income: Increased 6.1% to $6.7 million. The increase was aided by higher sales volume and the absence of the $1.25 million pension settlement loss recorded in the prior year.
- Backlog: Increased 12.8% to $65.9 million, driven by increased orders for custom pumps.
- Other Income: Decreased 39.8% due to unfavorable currency translation impacts on inter-company transactions.
Outlook, Risks, and Management Commentary
- Liquidity: The Company maintains a strong liquidity position with a current ratio of 4.2 to 1. Capital expenditures and working capital are financed through internally generated funds, unsecured lines of credit, and short-term investments.
- Market Risk: Foreign operations are small and do not present material market risks. Export sales are predominantly denominated in U.S. dollars.
- Controls: Management concluded that disclosure controls and procedures are effective as of September 30, 2004, with no material weaknesses identified.
- Risks: Forward-looking statements are subject to risks including changes in the business environment, competitor responses, new product development success, government regulations, and conditions in emerging economies.
- Accounting Changes: The Company adjusted cost of products sold and SG&A to include amortization expense previously classified as other expense. Additionally, the impact of the Medicare Part D subsidy on postretirement benefits has not yet been reflected in financial statements pending actuarial equivalence determination.
Investor Verification Checklist
- Verify the impact of municipal capital spending postponements on future revenue streams.
- Confirm the sustainability of the backlog increase ($65.9 million) and its conversion rate to revenue.
- Monitor the resolution of the Medicare Part D subsidy determination and its potential effect on postretirement benefit obligations.
- Review the ongoing costs associated with Sarbanes-Oxley compliance and their impact on SG&A margins.
- Assess the volatility of currency translation effects on inter-company transactions and other income.